Entry Detail



General Information

Database ID:exR0359258
RNA Name:ABL1
RNA Type:mRNA
Chromosome:chr9
Starnd:+
Coordinate:
Start Site(bp):130713016End Site(bp):130887675
External Links:ENSG00000097007



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CXCL12
chr10
44370165
44386493
-
ASXL2
chr2
25733753
25878487
-
TMEM115
chr3
50354750
50359521
-
STK11
chr19
1177558
1228431
+
TMEM214
chr2
27032910
27041694
+
NOP53
chr19
47745546
47757058
+
TSC2
chr16
2047967
2089491
+
CHTOP
chr1
153633982
153646306
+
ZMYM3
chrX
71239624
71255146
-
NUTF2
chr16
67846923
67872567
+
DBNDD2
chr20
45406057
45410610
+
PCGF2
chr17
38733898
38749817
-
TM9SF3
chr10
96518110
96587452
-
CHD4
chr12
6570082
6614524
-
AP000350.4
chr22
23862188
23895223
+
PLCG1
chr20
41136960
41196801
+
ACTB
chr7
5527148
5563784
-
ATE1
chr10
121740421
121928801
-
TSPAN6
chrX
100627108
100639991
-
TRAF2
chr9
136881912
136926607
+
HMGN4
chr6
26538366
26546933
+
ETS2
chr21
38805183
38824955
+
LAMP5
chr20
9514358
9530524
+
MOV10
chr1
112673141
112700746
+
GLUL
chr1
182381704
182392206
-
TPM4
chr19
16067021
16103002
+
SIGIRR
chr11
405716
417455
-
HNRNPD
chr4
82352498
82374503
-
CORO7
chr16
4354542
4425705
-
ZNF319
chr16
57994668
58000453
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-432-5p
chr14
100884496
100884518
+
hsa-miR-520a-5p
chr19
53690895
53690915
+
hsa-miR-650
chr22
22822791
22822811
+
hsa-miR-330-5p
chr19
45639049
45639070
-
hsa-miR-760
chr1
93846880
93846899
+
hsa-miR-1270
chr19
20399320
20399342
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007993.3
chr17
43914433
43923001
-
AC069281.2
chr7
100572232
100578700
-
NEAT1
chr11
65422774
65445540
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.